ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2201

Developing a Comprehensive Patient-Specific Disease Progression Prediction Model for Knee Osteoarthritis Using Machine/Deep Learning Methods

Afshin Jamshidi 1, Mickael Leclercq 2, Jean-Pierre Pelletier 3, Aurèlie Labbe 4, François Abram 5, Arnaud Droit 6 and Johanne Martel-Pelletier7, 1University of Montreal Hospital Research Centre (CRCHUM); Laval University Hospital Research Centre, Québec, QC, Canada, 2Laval University Hospital Research Centre, q, QC, Canada, 3University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, 4Department of Decision Sciences, HEC Montréal, Montreal, QC, Canada, 5ArthroLab Inc., Montreal, QC, Canada, 6Laval University Hospital Research Centre, Québec, QC, Canada, 7University of Montreal Hospital Research Centre (CRCHUM), Montreal, Canada

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Knee osteoarthritis, machine learning and deep learning, osteoarthritis progressors, prediction models

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Osteoarthritis – Clinical Poster II

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Current assessment of knee osteoarthritis (OA) is primarily based on a patient’s personal and familial history, clinical features, and on radiographies. However, such information does not provide enough evidence to lead to a robust prediction/prognosis of OA fast progressors. This study aims to identify early significant predictors of knee OA progression using advanced machine learning (ML) and deep learning (DL) algorithms and propose a prediction model based on a short number of selected predictors and outcomes.

Methods: We used six feature selection models, including LASSO (Least Absolute Shrinkage and Selection Operator), Elastic Net, GBM (Gradient Boosting machine), RF (Random Forest), IG (Information Gain), and DL-based Multi-Layer Perceptron [MLP]. In addition, more than 100 classification methods were tested on five outcomes: incidence of cartilage volume loss in medial plateau at 48 and 96 months (Prop_CV_48-96), knee replacement (TKR) at 48-96 months, Kellgren-Lawrence (KL) grade ≥2 and medial joint space narrowing (JSN) ≥1 mm at 48 months. Data were retrieved from the Osteoarthritis Initiative and quantitative magnetic resonance imaging (MRI) assessment. This study included 1044-1598 individuals/outcome, as well as 1107 variables and 135 MRI data at baseline. The classification was done using auto-ML tools by calculating the area under curve (AUC) and Matthews correlation coefficient (MCC) for the imbalanced TKR data. To prioritize the selected variables and outcomes, we used the multi-label Sparse Partial Least Square (sPLS) regression method.

Results: Feature selection and sPLS revealed MRI-based variable cartilage thickness and outcome cartilage volume loss at 96 months (Prop_CV_96) as the best predictors of knee OA progression. Moreover, medial joint space width along with pain were among the top predictors. The LASSO method outperformed other feature selection methods (AUC, 0.75-0.91). For the 1-label classification of top common variables between the models, MLP achieved the highest AUC in Prop_CV_96, KL, and JSN (0.80, 0.99, 0.95). For Prop_CV_48 and TKR outcomes, GBM was the best classifier (AUC, 0.70, 0.99).

Conclusion: This is the first time that such a comprehensive study is performed for identifying the best predictors of knee OA rapid progressors. Importantly, data showed that MRI-based variables and outcome have the most significant impact in identifying OA progressors, and could be applied for early prognosis in clinical practice.


Disclosure: A. Jamshidi, None; M. Leclercq, None; J. Pelletier, ArthroLab Inc., 1, TRB Chemedica, 5; A. Labbe, None; F. Abram, ArthroLab Inc., 3; A. Droit, None; J. Martel-Pelletier, ArthroLab Inc., 1, TRB Chemedica, 5.

To cite this abstract in AMA style:

Jamshidi A, Leclercq M, Pelletier J, Labbe A, Abram F, Droit A, Martel-Pelletier J. Developing a Comprehensive Patient-Specific Disease Progression Prediction Model for Knee Osteoarthritis Using Machine/Deep Learning Methods [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/developing-a-comprehensive-patient-specific-disease-progression-prediction-model-for-knee-osteoarthritis-using-machine-deep-learning-methods/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/developing-a-comprehensive-patient-specific-disease-progression-prediction-model-for-knee-osteoarthritis-using-machine-deep-learning-methods/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology